The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Soluble HLA‐A,‐B,‐C and ‐G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation
Open accessAbstract
There is convincing evidence that soluble HLA‐A,‐B,‐C (sHLA‐A,‐B,‐C) and soluble HLA‐G (sHLA‐G) antigens can induce apoptosis in CD8+ activated T cells although there is scanty and conflicting information about the mechanism(s) by which sHLA‐A,‐B,‐C antigens and sHLA‐G antigens induce apoptosis. In this study we have compared the apoptosis‐inducing ability of sHLA‐A,‐B,‐C antigens with that of sHLA‐G1 antigens in CD8+ T lymphocytes and CD8+ NK cells. Furthermore we have compared the inhibitory effect of sHLA‐A,‐B,‐C antigens and of sHLA‐G1 antigens on theactivity of EBV‐specific CD8+ cytotoxic T lymphocytes (CTL). sHLA molecules were purified from serum and from the supernatant of HLA class I‐negative cells transfected with one gene encoding either classical or non‐classical HLA class I antigens. Both classical and non‐classical sHLA class I molecules trigger apoptosis in CD8+ T lymphocytes and in CD8+ NK cells, which lack the T cell receptor, and their apoptotic potency is comparable. The binding of sHLA‐A,‐B,‐C and sHLA‐G1 molecules to CD8 leads to Fas ligand (FasL) up‐regulation, soluble FasL (sFasL) secretion and CD8+ cell apoptosis by Fas/sFasL interaction. Moreover, classical and non‐classical sHLA class I molecules inhibit the cytotoxic activity of EBV‐specific CD8+ CTL. As the amount ofsHLA‐G molecules detectable in normal serum is significantly lower than that of sHLA‐A,‐B,‐C molecules, the immunomodulatory effects of sHLA class I molecules purified from serum are likely to be mainly attributable to classical HLA class I antigens. As far as the potential in vivo relevance of these findings is concerned, we suggest that classical sHLA class I molecules may play a major immunoregulatory role in clinical situations characterized by activation of the immune system and elevated sHLA‐A,‐B,‐C serum levels. In contrast, non‐classical HLA class I molecules may exert immunomodulatory effects in particular conditions characterized by elevated sHLA‐G levels such as pregnancy and some neoplastic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Separation of leukocytes from blood and bone marrow
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 2,696
Barnstable, C. (1978) · Cell · doi:10.1016/0092-8674(78)90296-9 · Cited by 1,916
Major histocompatibility antigens: The human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules
Ploegh, H. L., Orr, H. T., & Strominger, J. L. (1981) · Cell · doi:10.1016/0092-8674(81)90318-4 · Cited by 520
Ishitani, A., & Geraghty, D. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3947 · Cited by 515
Fournel, S., Aguerre-Girr, M., Huc, X., Lenfant, F., Alam, A., Toubert, A., Bensussan, A., & Le Bouteiller, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6100 · Cited by 463
A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.
Fujii, T., Ishitani, A., & Geraghty, D. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5516 · Cited by 362
Lila, N., Rouas-Freiss, N., Dausset, J., Carpentier, A., & Carosella, E. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201407398 · Cited by 314
Lee, N., Malacko, A. R., Ishitani, A., Chen, M.-C., Bajorath, J., Marquardt, H., & Geraghty, D. E. (1995) · Immunity · doi:10.1016/1074-7613(95)90130-2 · Cited by 312
Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes
Zavazava, N., & Krönke, M. (1996) · Nature Medicine · doi:10.1038/nm0996-1005 · Cited by 262
Detection of soluble HLA‐G molecules in plasma and amniotic fluid
Rebmann, V., Pfeiffer, K., Päßler, M., Ferrone, S., Maier, S., Weiss, E., & Grosse‐Wilde, H. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530102.x · Cited by 185
Self-citationStructure and function of the human MHC class Ib molecules HLA‐E, HLA‐F and HLA‐G
O'Callaghan, C. A., & Bell, J. I. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01192.x · Cited by 173
Soluble HLA-G circulates in maternal blood during pregnancy
Hunt, J. S., Jadhav, L., Chu, W., Geraghty, D. E., & Ober, C. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106762 · Cited by 172
Porto, J. D., Johansen, T. E., Čatipović, B., Parfiit, D. J., Tuveson, D. A., Gether, U., Kozlowski, S., Fearon, D. T., & Schneck, J. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6671 · Cited by 141
Serum HLA class I antigens: markers and modulators of an immune response?
Puppo, F., SCUDELETTI, M., Indiveri, F., & Ferrone, S. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80127-8 · Cited by 122
Self-citationPELLEGRINO, M. A., Ng, A., RUSSO, C., & Ferrone, S. (1982) · Transplantation · doi:10.1097/00007890-198207000-00004 · Cited by 119
Self-citationPuppo, F., Contini, P., Ghio, M., Brenci, S., Scudeletti, M., Filaci, G., Ferrone, S., & Indiveri, F. (2000) · International Immunology · doi:10.1093/intimm/12.2.195 · Cited by 114
Self-citationSpaggiari, G. M., Contini, P., Carosio, R., Arvigo, M., Ghio, M., Oddone, D., Dondero, A., Zocchi, M. R., Puppo, F., Indiveri, F., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1706 · Cited by 80
Self-citationXu, X.-N., Purbhoo, M. A., Chen, N., Mongkolsapaya, J., Cox, J. H., Meier, U., Tafuro, S., Dunbar, P. R., Sewell, A. K., Hourigan, C. S., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00133-9 · Cited by 74
Soluble HLA antigens: new roles and uses
Puppo, F., Indiveri, F., SCUDELETTI, M., & Ferrone, S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)84660-9 · Cited by 41
Self-citationContini, P., Ghio, M., Merlo, A. C., Brenci, S., Filaci, G., Indiveri, F., & Puppo, F. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00212-3 · Cited by 34
Self-citation
Cited by
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Mohme, M., Riethdorf, S., & Pantel, K. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.144 · Cited by 602
Leone, P., Shin, E.-C., Perosa, F., Vacca, A., Dammacco, F., & Racanelli, V. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt184 · Cited by 553
HLA‐G and immune tolerance in pregnancy
Hunt, J. S., Petroff, M. G., McIntire, R. H., & Ober, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2078rev · Cited by 524
Kim, J. W., Wieckowski, E., Taylor, D. D., Reichert, T. E., Watkins, S., & Whiteside, T. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1010.11.3 · Cited by 497
Carosella, E. D., Rouas-Freiss, N., Roux, D. T.-L., Moreau, P., & LeMaoult, J. (2015) · Advances in Immunology · doi:10.1016/bs.ai.2015.04.001 · Cited by 395
Metadata
- Authors
- Contini, P., Ghio, M., Poggi, A., Filaci, G., Indiveri, F., Ferrone, S., & Puppo, F.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2002-12-20
- Volume
- 33
- Issue
- 1
- Pages
- 125-134
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1970410047
- Cited by
- 358
- References
- 20
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.